FDA

Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels

Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels

Biocon share price jumped nearly 4 percent during early trades as the company received FDA approval for biosimilar drug Yesintek. Biocon touched intraday high of Rs 380 after opening at Rs 375.

Abbott wins 5-Minute Coronavirus Test Approval for US Government

Abbott wins 5-Minute Coronavirus Test Approval for US Government

Abbott has won approval for its quick coronavirus test from the US government, the company informed on Friday.